Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two clinical trials are on-going in Vietnam and Myanmar, investigating the efficacy and safety of sofosbuvir and daclatasvir in the treatment of Hepatitis C. Bioanalytical assays will be developed to quantify these drugs in biological fluids, such as plasma and whole blood. Pharmacokinetic and pharmacodynamic samples will be collected in these studies so that the pharmacokinetic properties can be evaluated, and linked to their pharmacodynamic effect (viral elimination).